VeraBank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $255K | Sell |
4,429
-265
| -6% | -$15.2K | 0.04% | 152 |
|
|
2026
Q1 | $285K | Sell |
4,694
-47
| -1% | -$2.74K | 0.05% | 151 |
|
|
2025
Q4 | $256K | Sell |
4,741
-33
| -0.7% | -$1.59K | 0.05% | 163 |
|
|
2025
Q3 | $215K | Sell |
4,774
-1,834
| -28% | -$85.7K | 0.04% | 178 |
|
|
2025
Q2 | $306K | Buy |
6,608
+271
| +4% | +$13.3K | 0.06% | 151 |
|
|
2025
Q1 | $386K | Buy |
6,337
+29
| +0.5% | +$1.69K | 0.11% | 109 |
|
|
2024
Q4 | $357K | Sell |
6,308
-191
| -3% | -$10.7K | 0.1% | 111 |
|
|
2024
Q3 | $336K | Sell |
6,499
-100
| -2% | -$4.69K | 0.1% | 116 |
|
|
2024
Q2 | $274K | Hold |
6,599
| – | – | 0.09% | 124 |
|
|
2024
Q1 | $358K | Sell |
6,599
-47
| -0.7% | -$2.39K | 0.11% | 111 |
|
|
2023
Q4 | $341K | Sell |
6,646
-2
| -0% | -$105 | 0.11% | 110 |
|
|
2023
Q3 | $386K | Hold |
6,648
| – | – | 0.15% | 104 |
|
|
2023
Q2 | $425K | Hold |
6,648
| – | – | 0.16% | 97 |
|
|
2023
Q1 | $461K | Hold |
6,648
| – | – | 0.21% | 88 |
|
|
2022
Q4 | $478K | Sell |
6,648
-2
| -0% | -$151 | 0.24% | 79 |
|
|
2022
Q3 | $472K | Sell |
6,650
-861
| -11% | -$62.5K | 0.3% | 73 |
|
|
2022
Q2 | $578K | Buy |
7,511
+40
| +0.5% | +$3.05K | 0.34% | 69 |
|
|
2022
Q1 | $546K | Hold |
7,471
| – | – | 0.28% | 79 |
|
|
2021
Q4 | $466K | Hold |
7,471
| – | – | 0.24% | 87 |
|
|
2021
Q3 | $442K | Hold |
7,471
| – | – | 0.25% | 85 |
|
|
2021
Q2 | $499K | Hold |
7,471
| – | – | 0.3% | 74 |
|
|
2021
Q1 | $472K | Buy |
7,471
+100
| +1% | +$6.22K | 0.31% | 74 |
|
|
2020
Q4 | $457K | Hold |
7,371
| – | – | 0.32% | 70 |
|
|
2020
Q3 | $444K | Hold |
7,371
| – | – | 0.34% | 68 |
|
|
2020
Q2 | $433K | Sell |
7,371
-533
| -7% | -$31.9K | 0.35% | 68 |
|
|
2020
Q1 | $440K | Hold |
7,904
| – | – | 0.43% | 62 |
|
|
2019
Q4 | $508K | Buy |
7,904
+779
| +11% | +$44.6K | 0.41% | 63 |
|
|
2019
Q3 | $362K | Buy |
7,125
+361
| +5% | +$17K | 0.33% | 67 |
|
|
2019
Q2 | $307K | Hold |
6,764
| – | – | 0.29% | 74 |
|
|
2019
Q1 | $323K | Hold |
6,764
| – | – | 0.31% | 73 |
|
|
2018
Q4 | $352K | Buy |
+6,764
| New | +$363K | 0.38% | 63 |
|
Other funds holding BMY
VeraBank's BMY Position: Q2 2026 in Review
VeraBank reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, selling an estimated $15.2K and leaving 4,429 shares worth $255K. The position accounts for 0.04% of the portfolio, ranked #152.
VeraBank first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $578K in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- VeraBank held 4,429 shares of Bristol-Myers Squibb worth $255K as of Q2 2026.
- VeraBank sold 265 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.2K.
- Bristol-Myers Squibb made up 0.04% of VeraBank's portfolio in Q2 2026, its #152 holding.
- VeraBank first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- VeraBank's Bristol-Myers Squibb position peaked at $578K in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.